Nurse Practitioner, Family · New Orleans, LA
NPI
1679918692
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1401 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4747
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
468 services
Medicare patients, 2024
158
Average age 72
Drug cost, 2024
$4.5M
9,048 prescriptions
Company payments, 2025
$922
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irielle L Banks was code 99214 (office e&m - established), 263 times for 124 patients. In total Irielle L Banks billed 468 services in 8 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 263 | 124 | $56.84 | $15K |
| 95251 Test - Miscellaneous | Facility | 114 | 60 | $21.67 | $2,471 |
| 99214 Office E&M - Established | Office | 56 | 33 | $76.14 | $4,264 |
| 99442 Telephone Services | Office | 11 | 11 | $53.39 | $587 |
By year: 2022 $21K for 417 services; 2023 $22K for 462 services; 2024 $23K for 468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irielle L Banks prescribed most often to Medicare patients was Ozempic (Semaglutide), with 717 prescriptions and refills. In total Irielle L Banks wrote 9,048 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 717 | 1,067 | 147 | $1.0M |
| Mounjaro Tirzepatide | 713 | 810 | 125 | $852K |
| Jardiance Empagliflozin | 351 | 669 | 91 | $388K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 343 | 724 | 118 | $43K |
| Trulicity Dulaglutide | 327 | 403 | 63 | $391K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 326 | 696 | 133 | $32K |
| Metformin Hcl Generic | 320 | 942 | 107 | $2,248 |
| Novolog Flexpen Insulin Aspart | 275 | 505 | 99 | $82K |
| Glipizide Er Glipizide | 262 | 719 | 72 | $2,137 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 237 | 483 | 75 | $132K |
| Metformin Hcl Er Metformin Hcl | 223 | 632 | 77 | $1,982 |
| Humalog Kwikpen U-100 Insulin Lispro | 187 | 263 | 55 | $47K |
| Glipizide Generic | 171 | 465 | 50 | $995 |
| Atorvastatin Calcium Generic | 164 | 474 | 59 | $1,379 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 151 | 266 | 48 | $109K |
Brand drugs: 4,975 claims; generic drugs: 2,922 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irielle L Banks $922 ($922 in general payments such as food, travel and fees) from 6 companies. The largest payer was Beta Bionics, Inc. with $326.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.